Literature DB >> 8549359

Effect of ferrous sulfate on the absorption of sparfloxacin in healthy volunteers and rats.

K Kanemitsu1, S Hori, A Yanagawa, J Shimada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549359     DOI: 10.2165/00003495-199500492-00096

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  4 in total

1.  Intestinal absorption of a beta-adrenergic blocking agent nadolol. I. Comparison of absorption behavior of nadolol with those of other beta-blocking agents in rats.

Authors:  T Yamaguchi; C Ikeda; Y Sekine
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-08       Impact factor: 1.645

2.  Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers.

Authors:  R E Polk; D P Healy; J Sahai; L Drwal; E Racht
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

3.  Norfloxacin interaction with antacids and minerals.

Authors:  N R Campbell; M Kara; B B Hasinoff; W M Haddara; D W McKay
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

4.  The effects of ions on antibacterial activity of ofloxacin and ceftriaxone.

Authors:  H Gürdal; S Usanmaz; F C Tulunay
Journal:  Chemotherapy       Date:  1991       Impact factor: 2.544

  4 in total
  3 in total

1.  The new fluoroquinolones: A critical review.

Authors:  G G Zhanel; A Walkty; L Vercaigne; J A Karlowsky; J Embil; A S Gin; D J Hoban
Journal:  Can J Infect Dis       Date:  1999-05

2.  The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin.

Authors:  M Kamberi; H Nakashima; K Ogawa; N Oda; S Nakano
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

Review 3.  Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections.

Authors:  K L Goa; H M Bryson; A Markham
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.